trending Market Intelligence /marketintelligence/en/news-insights/trending/EOD2c3yajYKADseoHswAFQ2 content esgSubNav
In This List

Global Blood Therapeutics closes $100M common stock offering

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Global Blood Therapeutics closes $100M common stock offering

Global Blood Therapeutics Inc. closed its underwritten public offering of 2,631,579 common shares at $38 per share for expected gross proceeds of about $100 million.

In addition, the underwriters including Cantor Fitzgerald & Co., acting as a representative of the several underwriters, have a 30-day option to buy 394,736 additional common shares.